AMED Challenges for Overcoming Balkanization
Japan Agency for Medical Research and Development (AMED)
AMED launched Initiative for Rare and Undiagnosed Diseases (IRUD) as the fast leading project. Solving "Balkanization" among different sectors in IRUD which participate in medical R&D gives a clue to fast-track implementation of outcomes among all other fields of medical researches.
Makoto Suematsu has been the President of the Japan Agency for Medical Research and Development since April 2015. He graduated from Keio University School of Medicine in 1983. After serving as a research assistant at Keio University, he went to Institute for Biomedical Engineering at University of California San Diego as a bioengineer in 1991. He became a professor and the Chair of Department for Biochemistry at Keio University School of Medicine in 2001, and served as the Dean of Keio University School of Medicine from October 2007 to March 2015.
Integration of Information Revolution and Biomedical Revolution: Predictive and Preventive Medicine Based on IoT and AI
Sony Computer Science Laboratories, Inc. /
Senior Researcher, Medical Business Unit,
Sony Corp. /
Deputy Director, Medical Sciences Innovation Hub Program,
Paradigm shift in healthcare and medicine is required. That is a transformation from one-size fit all medicine to personalize medicine and treatment to prevention. These changes will actualize by sensor technologies, IoT and AI. I would like to discuss on how information technologies and biomedical technologies are integrated in near future.
Dr. Kazuhiro Sakurada has been working for Sony CSL as a senior researcher since September 2008. He served as Head of Research Center Japan, Head of Therapeutic Research Group Regenerative Medicine and member of Global Research Management Team for Bayer Schering Pharma, as well as a member of the Executive Committee of Bayer Yakuhin until December 2007. Before joining Sony CSL, he served as Chief Scientific Officer of US based start-up company iZumi Bio founded by Kleiner Perkins Caufield & Byers to transfer human iPS cell technologies developed in Bayer Research Center Japan.
Life Sciences Potential in Lithuania
Ministry of Economy of Republic of Lithuania
* Please note that the speaker has changed as above. (As of Monday, April 25, 2016)
To improve the international competitiveness and economic vibrancy in Lithuania, governmental institutions, and the whole science and business ecosystem join their forces to establish an environment for attracting new joint businesses with partners from abroad. The potential of Lithuania`s life sciences industry will be presented.
Marius Skarupskas appointed Vice-minister of Economy of Lithuania 10 January, 2013 with primary responsibility for Lithuanian business and commerce environment, innovations and European Union funding. Prior he served as Head of a division, Lecturer, Expert, worked in private and public sectors. M. Skarupskas holds Master and Bachelor Degrees in Communication and Information of Vilnius University.